NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.870
-0.080 (-2.71%)
Apr 29, 2026, 10:08 AM EDT - Market open
NRx Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Net Income | -28.62 | -25.13 | -30.15 | -39.75 | -93.06 | Upgrade
|
| Depreciation & Amortization | 0.14 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Other Amortization | 0.35 | 0.9 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.04 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.83 | 0.52 | 0.39 | 3.63 | 7.79 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.04 | - | - | - | - | Upgrade
|
| Other Operating Activities | 11.7 | 7.77 | 2.94 | -4.33 | 52.47 | Upgrade
|
| Change in Accounts Receivable | 0.05 | - | - | - | 0.83 | Upgrade
|
| Change in Accounts Payable | 0.11 | -5.22 | 2.66 | -1.61 | -0.02 | Upgrade
|
| Change in Other Net Operating Assets | 1.25 | 10.51 | 2.51 | 2.31 | -5.71 | Upgrade
|
| Operating Cash Flow | -14.11 | -10.64 | -21.66 | -39.76 | -37.7 | Upgrade
|
| Capital Expenditures | - | - | -0 | -0.01 | -0.01 | Upgrade
|
| Cash Acquisitions | -2.38 | - | - | - | - | Upgrade
|
| Investment in Securities | -0.43 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -2.81 | - | -0 | -0.01 | -0.01 | Upgrade
|
| Short-Term Debt Issued | 0.23 | 1.05 | 0.94 | - | - | Upgrade
|
| Long-Term Debt Issued | 5 | 6.03 | - | 10.02 | - | Upgrade
|
| Total Debt Issued | 5.23 | 7.08 | 0.94 | 10.02 | - | Upgrade
|
| Short-Term Debt Repaid | -0.55 | -0.73 | -0.94 | - | -0.18 | Upgrade
|
| Long-Term Debt Repaid | - | -7.85 | -3.09 | -0.52 | -1.1 | Upgrade
|
| Total Debt Repaid | -0.55 | -8.58 | -4.04 | -0.52 | -1.28 | Upgrade
|
| Net Debt Issued (Repaid) | 4.68 | -1.5 | -3.09 | 9.5 | -1.28 | Upgrade
|
| Issuance of Common Stock | 9.47 | 5.91 | 8.12 | 22.71 | 53.68 | Upgrade
|
| Other Financing Activities | 9.13 | 3.07 | - | - | 11.05 | Upgrade
|
| Financing Cash Flow | 23.28 | 7.49 | 6.2 | 32.21 | 63.46 | Upgrade
|
| Net Cash Flow | 6.35 | -3.15 | -15.46 | -7.55 | 25.75 | Upgrade
|
| Free Cash Flow | -14.11 | -10.64 | -21.66 | -39.77 | -37.71 | Upgrade
|
| Free Cash Flow Margin | -1152.00% | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.66 | -1.00 | -2.86 | -6.05 | -8.04 | Upgrade
|
| Cash Interest Paid | - | 0.37 | 0.89 | - | - | Upgrade
|
| Levered Free Cash Flow | -0.81 | 0.13 | -11.47 | -28.24 | -89.8 | Upgrade
|
| Unlevered Free Cash Flow | -0.74 | -0.63 | -11.4 | -28.24 | -89.79 | Upgrade
|
| Change in Working Capital | 1.41 | 5.29 | 5.16 | 0.7 | -4.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.